{
    "title": "Britain's Immunocore raises $320 mln in record financing round",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3163388/Britains-Immunocore-raises-320-mln-record-financing-round.html",
    "date": "2015-07-16",
    "keywords": [
        "investment",
        "immunocore",
        "july",
        "life",
        "technology",
        "funding",
        "immune",
        "system",
        "gmt",
        "company",
        "thursday",
        "malin",
        "cancer",
        "power",
        "tcell",
        "euros",
        "market",
        "march",
        "mln",
        "record",
        "financing",
        "round",
        "email",
        "halpindublin",
        "woodford",
        "managementthe",
        "biotech",
        "compnay",
        "pipeline",
        "nextgeneration",
        "healthcare",
        "endorsement",
        "executive",
        "eliot",
        "forster",
        "statementthis",
        "advancement",
        "imcgp100",
        "clinic",
        "drug",
        "melanoma",
        "phase",
        "trial",
        "part",
        "infection",
        "immtacs",
        "cellstraditional",
        "surface",
        "bodys",
        "salesthe",
        "support",
        "research",
        "licensing",
        "roche",
        "glaxosmithkline",
        "astrazenecaimmunocore",
        "number",
        "firm",
        "science",
        "stock",
        "placementit",
        "issue",
        "price",
        "interest",
        "shareholder",
        "perspective",
        "opportunity",
        "ceo",
        "howd",
        "board",
        "reutersthis",
        "subscribed",
        "stage",
        "something",
        "valueadaptimmune",
        "receptor",
        "engineering",
        "offering",
        "capitalisation",
        "eurosediting",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}